Northwest Biotherapeutics (NWBO) Interest & Investment Income (2010)
Northwest Biotherapeutics' (NWBO) quarterly Interest & Investment Income came in at $489000.0 in Q4 2010.
Northwest Biotherapeutics (NWBO) Interest & Investment Income (2010) Analysis & Trends
Northwest Biotherapeutics' Interest & Investment Income history runs 1 years deep, the most recent figure standing at $489000.0 for Q4 2010.
- On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $489000.0 in Q4 2010; TTM through Sep 2011 was $489000.0, a N/A change from a year earlier, with the FY2010 full-year figure at $489000.0, changed N/A from the prior year.
- Interest & Investment Income steadied at $489000.0 in Q4 2010 per NWBO's latest filing.
- Across five years, Interest & Investment Income topped out at $489000.0 in Q4 2010 and bottomed at $489000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Northwest Biotherapeutics | 272.75 Mn | 270.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 489,000.00 |